Investors
Enhancing Women’s Health. Empowering WOmen’s Lives.
Source: FemTech Landscape 2021 Annual Report, Crunchbase
WOMEN’S HEALTH IS A
$1.186 TRILLION
MARKET IN NEED OF DISRUPTION & TRUE SOLUTIONS
As the best Women’s CRO
EXO is the core foundation of this over $1 T Market.
Executive Summary
-
who we are
EXO is the premier women’s clinical research organization (CRO) that leverages women’s health insights to redefine care, engineer innovative treatments, and promote cutting-edge interventions toward pain remediation and overall health and wellness.
Founded by women and for women, we are entirely devoted to resolving disparities in women’s health research and treatment.
EXO’s purpose is to improve women’s health and empower women in our everyday lives.
-
WE ARE EXPERTS & THIS IS OUR PURPOSE
At EXO, We believe addressing inequalities and improving women’s health is one of the most significant and impactful opportunities of our lifetime.
We are uniquely equipped to champion this mission.
We have cultivated the best team of experts in the world.
We are led by a visionary founder, and surrounded by the most distinguished, internationally recognized, and award-winning scientists and board-certified physicians.
We are a team of trailblazers who have been dedicated to advancing women’s health, research and treatment for decades.
EXO is the manifestation of our purpose and the culmination of our life’s work.
There is still great work to be done.
We are just getting started.
-
Why EXO
We are experts who understand the nuances in women’s health, research, treatment, and the regulatory processes necessary to bring the best solutions to market.
That’s why at EXO we take a full service, end-to-end approach.
To develop the most innovative interventions & treatments for women, we leverage our proprietary:
• Clinical Research
• Patient Data
• Human Insights
• Data Insights
• Machine Learning & AI
WHAT BEING A WOMEN’S CRO MEANS AT EXO.
As the premier Women’s CRO we are the core foundation of the over $1 T Women’s Health Market.
We bridge the gap between disparities in women’s health research and female-focused health solutions.
Only 4% of all healthcare research and development is targeted specifically at women’s health issues-despite the estimated $500 billion annual economic burden for women.
That means there are huge fundamental gaps in the clinical data available around women’s health.
The lack of scientific knowledge results in a lack of innovation, higher barriers for FDA approval, and keeps this market marginalized.
We need better insights to provide better solutions.
Pitchbook’s 2020 Report stated:
“We believe new approaches to women’s health research will help open the door to new products and services”
That’s exactly what we aim to do at EXO.
THe Problem:
There are Huge Disparities in Women’s Healthcare Research & Treatment
-
Lack of Clinical Research on Women
-
Traditional CROs are using the Wrong, Outdated, Antiquated Approach
-
We Need Better Insights to Provide Better Solutions
By the Numbers:
-
Lack of Clinical Research on Women
Women have historically been excluded from research due to fear of hormonal cycles interfering with experimental results or the risk of harming the fetus. Women were banned from clinical trials from 1977-1993, and even until the early 2000s, many landmark clinical trials in the US primarily had male participants.
Today, unfortunately, most clinical trials still continue to have mainly male participants.
Therefore, there are fundamental gaps in the clinical data available around women’s health. The lack of scientific knowledge results in a lack of innovation and higher barriers for FDA approval.
We need better insights to provide better solutions.
-
Women are at higher risk than men for certain diseases
on average:
38% OF WOMEN
across the world suffer from a Chronic Disease,
accounting for
1/3rd OF FEMALE MORTALITY.
-
Only 4% of R&D Budgets
GO TOWARDS SOLUTIONS FOR WOMEN’S HEALTH
– BCC Research Special Report
-
$500 Billion Economic Burden
THE ECONOMIC BURDEN FOR WOMEN’S DISEASES IS CURRENTLY ESTIMATED TO EXCEED $500 B
- BCC Research Special Report
Our focus Areas Now:
-
Obstetrics & Gynecology
$171 B
-
Pregnancy & Postpartum Care
$26 B
-
Pelvic Health
$16 B
-
EXO is starting by conducting clinical research and developing solutions for the most excluded, underrepresented, underserved, and underestimated population in healthcare:
Pregnant and Postpartum Women
EXO is leveraging our data-insights to develop unique and innovative interventions that alleviate pregnant and postpartum women’s pain.
-
Women experience pain points of pregnancy up to 36 months postpartum.
There are:
• Over 60 M women in childbearing years
• 3.75 M births in the US last year
• Approximately 1 of 6 women in the US is currently pregnant.
What we’re doing Now:
Postpartum Rehabilitation App & Website:
How EXO supports Postpartum Rehabilitation:
EXO equips and empowers women with the tools and resources they need as they transition from hospital to home.
The app will be recommended to women by their doctor as they transition from hospital to home. The website and app will serve as a guide for Postpartum Home Care.
Content will focus on:
Physical Health & Rehabilitation
Mental Health & Wellbeing
Our differentiator is that all content is developed with our medical experts: Dr. Meghan O’Hara and Dr. John Thorp. Developing our app with our board-certified physicians allows us to have the app approved by the FDA as software as a medical device. Having the app approved by the FDA validates the data.
For our Business this serves as:
Patient Registry
Continuous Patient Engagement
Patient Data Acquisition
Validated Data (FDA approved as software as a medical device)
Recruitment for Studies
CLINICAL RESEARCH & PATIENT DATA FROM PARTNERS:
We are currently:
Integrating clinical research & patient data from our partners.
Determining our initial data structures & models
Continuing to build partnerships with the top:
Physicians
Scientists
Researchers
Hospitals
Clinics
Organizations
Institutions
Networks
s is ently
CLINICAL STUDIES & CLINICAL TRIALS:
We design and conduct clinical studies & clinical trials:
Our initial study will be conducted with our experts: Dr. Meghan O’Hara, Dr. John Thorp, and Dr. LaJean Lawson:
Innovation of interventions in pain management: a longitudinal study of anatomical & physiological changes and their implications on pain & movement during pregnancy and postpartum
Results will be:
Unique, proprietary clinical research and raw data from our patient population
Published in Peer-Reviewed Medical Journals
Enable our data science experts to use results to continually refine our proprietary AI & Machine Learning algorithms
Leveraged to develop the most innovative interventions & treatments for women
ROBUST INTEGRATION OF REAL-WORLD EVIDENCE:
To benefit from advancements in telemedicine we integrate:
Real World Data
EMR/EHR
Medical IT
Clinical Research Infrastructures
& More
DEVELOPIng INNOVATivE INTERVENTIONS & TREATMENTS:
To develop the best innovative interventions & treatments for women we leverage our proprietary:
Clinical Research
Patient Data
Human Insights
Data Insights
Machine Learning & AI
& More
EXO’S Core Competencies:
Apps and Software
Productization of Data
Wearables
Sensors
Medical Devices
Smart Apparel
Pharmaceuticals
How we make money Now:
POSTPARTUM REHABILITATION APP & WEBSITE:
EXO equips and empowers women with the tools and resources they need as they transition from hospital to home.
Pricing:
Tiered Subscription Model:
$25/Month
$35/Month
$45/Month
Promo from Doctor/Affiliate:
$99/ 3 month premium app access
Willingness to pay for our app: our Medical Expertise and Board-Certified Physicians.
We intentionally develop our interventions and treatments with efficacy, integrity, and excellence.
The problem with free apps:
“Researchers at Columbia University Medical Center studied 108 free apps and concluded that 95% free smartphone menstrual cycle tracking apps for patient use are inaccurate. Few cite medical literature or health professional involvement.”-BCC Research Special Report: HLC226A Femtech: Empowering Women’s Health
Go To Market:
Recommended by Physicians as Postpartum Home Care
Strategic Partnerships with doctors, clinics, and hospitals
Current Partnerships:
Dr. Samantha Meltzer-Brody
Dr. John Thorp
Dr. Meghan O’Hara:
Results Physiotherapy: 170 Clinics
Social Media Marketing:
Physician Influencer Partnerships
Influencer Partnerships
Affiliate Links
Demo of our app!
FULL DEMO COMING SOON!!!
Our focus Areas Next:
-
Fertility
$72 B
-
Autoimmune & Chronic Conditions
$218 B
-
Perimenopause & Menopause
$53 B
How we make money Next:
Full Service WOmen’s CRO:
Insightful Evidence-Based Design & Development of Innovate Interventions & Treatments.
B2B Model
Consulting Services
Contract Research
Product Development
Software & Data Applications
Productization of Data:
API to License
Innovative Interventions & Treatments:
License or Sell
Future Partnerships
Current Projections:
POSTPARTUM REHABILITATION APP & WEBSITE Assumptions:
Tiered Subscription Model:
Intro: $25/Month
Standard: $35/Month
Premium: $45/Month
% of Each:
Intro: 35%
Standard: 40%
Premium: 25%
Funding:
10 Things exo will do with initial raise:
With $2M, We Will:
Team salaries
Beta of app
Continue website and content development
Initial data structures for ML & AI software
Integration of clinical research, data and patient information
Office, lab & equipment
Begin initial study:
Innovation of interventions in pain management: a longitudinal study of anatomical & physiological changes and their implications on pain & movement during pregnancy and postpartum
MVP of data-informed intervention
Legal
Marketing & branding
Are you ready to join us on this adventure?
Are you an investor aligned with our mission to champion advancements in women’s health research and treatment?
We’d love to connect with you to discuss how together we can impact the greater good.